Experimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
Quantitative Biology, Innovative Medicines and Early Development (IMED), AstraZeneca, Cambridge, UK.
Nat Protoc. 2017 Dec;12(12):2465-2477. doi: 10.1038/nprot.2017.118. Epub 2017 Nov 2.
We describe a sensitive, robust, high-throughput method for quantifying the ability of metastatic tumor cells to colonize a secondary organ. Metastasis is the leading cause of death in cancer patients, and successful colonization of the secondary organ is the rate-limiting step in the metastatic process; thus, experimental methods that can be used to interrogate the key factors required for this critical step are of great importance. The experimental metastasis assay we detail here includes tail-vein injection of cancer cells into the mouse and determination of the resulting secondary organ colonization, primarily in the lung, 10 d post dosing. This assay can be used to investigate factors that regulate metastatic colonization both at the tumor-cell-intrinsic level (via manipulation of the tumor cells before injection) and at the tumor-cell-extrinsic level (such as the tissue microenvironment, via the use of genetically modified (GM) mice or agents such as antibodies or drugs). Using this method, we have robustly screened more than 950 GM mouse lines to identify novel microenvironmental regulators of metastatic colonization. The experimental details discussed here include choosing of appropriate cell numbers, handling of the cells, selection of recipient animals and injection techniques. Furthermore, we discuss key experimental design considerations, including the choice of the method used to determine metastatic burden and statistical analysis of the results, as well as provide troubleshooting tips and identification of factors that contribute to experimental variability.
我们描述了一种灵敏、稳健、高通量的方法,用于定量分析转移性肿瘤细胞在次级器官中定植的能力。转移是癌症患者死亡的主要原因,而次级器官的成功定植是转移过程中的限速步骤;因此,能够用于研究这一关键步骤所需关键因素的实验方法非常重要。我们详细描述的实验性转移测定包括将癌细胞经尾静脉注射到小鼠体内,并在给药后 10 天测定次级器官(主要是肺部)的定植情况。该测定可用于研究在肿瘤细胞内在水平(通过在注射前对肿瘤细胞进行操作)和肿瘤细胞外在水平(如组织微环境,通过使用基因修饰 (GM) 小鼠或抗体或药物等试剂)调节转移定植的因素。使用这种方法,我们已经成功筛选了超过 950 条 GM 小鼠品系,以鉴定转移定植的新型微环境调控因子。这里讨论的实验细节包括选择适当的细胞数量、细胞处理、受体动物的选择和注射技术。此外,我们还讨论了关键的实验设计考虑因素,包括选择用于确定转移负担的方法和对结果进行统计分析,以及提供故障排除技巧和确定导致实验变异性的因素。